Pharming Group N.V. (PHAR) Financials
PHAR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 510.1 million | 267.8 million |
2023-09-30 | 462.1 million | 239.8 million |
2023-06-30 | 467.3 million | 249.5 million |
2023-03-31 | 464.1 million | 241.1 million |
PHAR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 13.1 million | ? |
2023-09-30 | 3.6 million | 2.1 million |
2023-06-30 | -11.3 million | 2.6 million |
2023-03-31 | -25.1 million | 1.7 million |
PHAR Net Income
No data available :(
PHAR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 235.9 million | - | - |
2023-09-30 | 209.2 million | - | 34.4 million |
2023-06-30 | 209.2 million | - | 37.1 million |
2023-03-31 | 226.0 million | - | 38.2 million |
PHAR Shares Outstanding
PHAR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 366393 | 12.9 million | - | - |
2023-09-30 | 155620 | 22.0 million | 11.5 million | 26.6 million |
2023-06-30 | 838335 | 22.7 million | 11.9 million | 36.9 million |
2023-03-31 | 234351 | 17.0 million | 10.9 million | 29.5 million |
PHAR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 90.5 million | 7.9 million |
2023-09-30 | 70.6 million | 8.8 million |
2023-06-30 | 59.7 million | 6.2 million |
2023-03-31 | 46.4 million | 4.4 million |
PHAR
Price: $10.45
52 week price:
Earnings Per Share: -0.33 USD
P/E Ratio: -40.74
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1500
Market Capitalization: 713.0 million
Average Dividend Frequency: 1